Delivery Order SPE2DB22D9239-SPE2DB24FDE42
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply 50 milligram vials of ADCETRIS pharmaceuticals. The $59,637.68 order has a completion date of December 18, 2023 and was awarded on November 27, 2023 without a set-aside designation. DMS Pharmaceutical Group will fulfill the order as the prime contractor, supplying the requested pharmaceutical item to DLA Troop Support Medical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-four thousand five hundred forty-seven dollars and ten cents ($74,547.10) by the Defense Logistics Agency. The delivery order is for ADCETRIS 50 MG vials to fulfill requirements under the prime vendor's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025....
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at forty-four thousand seven hundred twenty-eight dollars and twenty-six cents ($44,728.26) by the Defense Logistics Agency to provide fifty milligram vials of ADCETRIS under delivery order number 4562609300. The delivery order was awarded on October 23, 2023 and has a completion date of November 14, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. currently holds an...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand two hundred seventy-three dollars and fifty-five cents ($37,273.55) by the Defense Logistics Agency Troop Support Medical. This order was issued against the prime vendor's existing indefinite delivery contract to supply pharmaceutical items and medical products to military treatment facilities globally. Under this award, DMS Pharmaceutical Group will provide 50 mg vials of ADCETRIS,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $29,818.84 by the Defense Logistics Agency to provide 50 milligram vials of ADCETRIS under contract number 4563107240. The place of performance will be in Park Ridge, Illinois, with completion by December 18, 2023. DMS Pharmaceutical Group is a woman-owned small business that holds an indefinite delivery contract with the Defense Logistics Agency, worth up to $5 million through December 2025, to supply...
- The Defense Logistics Agency Troop Support Medical awarded a $36,045.64 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 50 mg vials of ADCETRIS under contract number 4561377931. DMS Pharmaceutical Group Inc. will deliver the specified pharmaceutical product to a location in Park Ridge, Illinois by July 14, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical supplies to support...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract for $37,273.55 to supply 50 mg vials of ADCETRIS. Performance will take place in Park Ridge, Illinois with completion by January 9, 2024. The order was awarded on December 15, 2023 without a set-aside designation. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group holds this prime vendor...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $45,943.92 contract is for the delivery of ADCETRIS 50 MG VIALS, with a completion date of February 20, 2024. The contract is issued against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025. This...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product ADCETRIS 50 MG VIALS. The order has a potential value of $30,629.28 and a completion date of February 7, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 50 mg vials of the pharmaceutical product ADCETRIS. The delivery order, with a potential value of $120,589.20, was awarded on February 24, 2022 and is set to be completed by March 17, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical supplies to the...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDE42Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 50 milligram vials of ADCETRIS, with a potential value of seventy-four thousand five hundred forty-seven dollars and ten cents ($74,547.10). The delivery order was awarded on November 16, 2023 and has a completion date of December 8, 2023. DMS Pharmaceutical Group will supply the pharmaceutical items to the Defense Logistics Agency Troop Support Medical facility located in Park Ridge, Illinois. No set-aside designation was used for this award. DMS Pharmaceutical Group holds its indefinite delivery contract with the Defense Logistics Agency through December 2025 to provide various medical supplies with a potential value up to five million dollars to support the routine needs of military treatment centers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.5k | 11/16/23 |